Results 61 to 70 of about 166,209 (279)

Green Synthesis of Silver Nanoparticles From Macaranga tanarius (L.) Mull. Arg. Leaf Extract With Enhanced Antibacterial, Antioxidant, and Tyrosinase Inhibitory Activities

open access: yesInternational Journal of Microbiology
Atopic dermatitis (AD) is a chronic inflammatory skin disorder characterized by microbial imbalance, particularly the overgrowth of Staphylococcus aureus.
Hsin-Ya Yeh   +7 more
doaj   +1 more source

Upadacitinib Restrains the Pathogenic Fitness of CD4+ T Cells and Aberrant B Cell Programming in Optic Neuritis

open access: yesAdvanced Science, EarlyView.
Single‐cell profiling and functional perturbation reveal coordinated JAK1‐pSTAT3 downstream programs in optic neuritis, including MCL1‐dependent fitness of pathogenic CD4+ Tem cells and glycolysis‐linked, cholesterol‐sensitive B‐cell responses associated with RORA. Upadacitinib disrupts this reciprocal T‐B‐cell circuit and alleviates neuroinflammation,
Gengchen Jiang   +12 more
wiley   +1 more source

The relationship between atopic dermatitis and atopic itch in children and the psychosocial functioning of their mothers: A cross-sectional study

open access: yesFrontiers in Medicine, 2023
Atopic dermatitis is a chronic inflammatory skin disease significantly affecting patients’ and their parents’ lives. Mothers are mostly responsible for the long-term treatment and their wellbeing is essential.
Aleksandra K. Kobusiewicz   +6 more
doaj   +1 more source

Eco-Friendly Synthesis of Silver Nanoparticles Using Sapindus mukorossi Extract With Antibacterial and Photocatalytic Activities

open access: yesScientifica
Green synthesis of silver nanoparticles (AgNPs) offers an eco-friendly approach for developing multifunctional nanomaterials. In this study, AgNPs were synthesized using Sapindus mukorossi fruit extract as both reducing and stabilizing agents. UV–visible
Mohit Chand   +5 more
doaj   +1 more source

Adult-onset atopic dermatitis

open access: yesIndian Journal of Dermatology, 2016
Adult-onset atopic dermatitis is still an under recognized condition as there are only few studies regarding this entity. As compared to childhood onset atopic dermatitis, clinical features of adult onset atopic dermatitis are still not categorized ...
Amrinder Jit Kanwar
doaj   +1 more source

Ultraviolet index: a light in atopic dermatitis and vitamin D research? [PDF]

open access: yesAnais Brasileiros de Dermatologia, 2016
BACKGROUND: The role played by vitamin D in atopic dermatitis is controversial and has been the focus of many studies. The ultraviolet index has not been considered in this type of research.
Kleyton de Carvalho Mesquita   +2 more
doaj   +1 more source

Clinical Longitudinal Evaluation After Regimen Stop (CLEAR) of Dupilumab in Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)

open access: yesInternational Forum of Allergy &Rhinology, EarlyView.
ABSTRACT Background Long‐term management strategies for severe chronic rhinosinusitis with nasal polyps (CRSwNP) increasingly include biologic therapy targeting Type 2 inflammation. However, data on outcomes after complete discontinuation of dupilumab following sustained disease control are scarce.
Patrick Huber   +7 more
wiley   +1 more source

Improvement of quality of life in patients with concomitant allergic asthma and atopic dermatitis: one year follow-up of omalizumab therapy

open access: yesEuropean Journal of Medical Research, 2011
Objective Anti IgE treatment with omalizumab is efficacious in the treatment of patients suffering from allergic asthma, improving asthma control and improving quality of life.
Velling P   +5 more
doaj   +1 more source

Advanced Pharmacological Treatment of Atopic Dermatitis

open access: yes, 2023
Atopic Dermatitis (AD) is a non-infectious, chronic, recurrent, inflammatory skin disease. The cause of AD is complex and multidimensional, and the disease manifests differently in each individual.
Hanspal, Sidak
core  

Biologics Adoption in CRSwNP and the Associated Decline in Endoscopic Sinus Surgery: A Longitudinal Claims Database Study

open access: yesInternational Forum of Allergy &Rhinology, EarlyView.
ABSTRACT Background Biologic treatments were introduced for chronic rhinosinusitis with nasal polyps (CRSwNP) in 2019. Treatment algorithms for medically refractory CRSwNP remain open, with patients choosing among surgery, biologics, or both. Real‐world utilization of surgery and biologics remains incompletely characterized.
Stephanie Shintani Smith   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy